Enterprise Value
50.45M
Cash
28.66M
Avg Qtr Burn
-3.178M
Short % of Float
0.36%
Insider Ownership
27.99%
Institutional Own.
18.49%
Qtr Updated
03/31/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
DM199 (KLK1 protein) Details Heart disease, Ischemic stroke | Phase 2/3 Update | |
DM199 (KLK1 protein) Details Chronic inflammatory disorder, Inflammatory disease, Kidney disease, IgA nephropathy, Chronic kidney disease | Phase 2 Data readout |